Workflow
瑞普生物:2023年和2024年公司累计回购1,068万股

Core Viewpoint - The company, Reap Bio (300119), announced its share repurchase and dividend distribution plans, highlighting its commitment to returning value to shareholders through significant cash dividends and stock repurchases [1] Group 1: Share Repurchase - In 2023 and 2024, the company plans to repurchase a total of 10.68 million shares [1] - The total amount allocated for the share repurchase is 190 million RMB [1] Group 2: Dividend Distribution - Since its listing, the company has distributed a total of 1.371 billion RMB in cash dividends [1] - The average dividend payout ratio stands at 44.32% [1] - The company has executed four stock splits, resulting in a 5.27 times expansion of its share capital compared to before its initial public offering [1]